[HTML][HTML] The first 12 months of COVID-19: a timeline of immunological insights
Since the initial reports of a cluster of pneumonia cases of unidentified origin in Wuhan,
China, in December 2019, the novel coronavirus that causes this disease—severe acute …
China, in December 2019, the novel coronavirus that causes this disease—severe acute …
Testing at scale during the COVID-19 pandemic
Assembly and publication of the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) genome in January 2020 enabled the immediate development of tests to detect the …
CoV-2) genome in January 2020 enabled the immediate development of tests to detect the …
Antibody tests for identification of current and past infection with SARS‐CoV‐2
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
Emerging telemedicine tools for remote COVID-19 diagnosis, monitoring, and management
The management of the COVID-19 pandemic has relied on cautious contact tracing,
quarantine, and sterilization protocols while we await a vaccine to be made widely available …
quarantine, and sterilization protocols while we await a vaccine to be made widely available …
Machine learning and computation-enabled intelligent sensor design
Over the past several decades the dramatic increase in the availability of computational
resources, coupled with the maturation of machine learning, has profoundly impacted …
resources, coupled with the maturation of machine learning, has profoundly impacted …
High‐affinity dimeric aptamers enable the rapid electrochemical detection of wild‐type and B. 1.1. 7 SARS‐CoV‐2 in unprocessed saliva
We report a simple and rapid saliva‐based SARS‐CoV‐2 antigen test that utilizes a newly
developed dimeric DNA aptamer, denoted as DSA1N5, that specifically recognizes the spike …
developed dimeric DNA aptamer, denoted as DSA1N5, that specifically recognizes the spike …
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers
Accurate serological assays to detect antibodies to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) are needed to characterize the epidemiology of SARS-CoV-2 …
coronavirus 2 (SARS-CoV-2) are needed to characterize the epidemiology of SARS-CoV-2 …
SERS based lateral flow immunoassay for point-of-care detection of SARS-CoV-2 in clinical samples
The current scenario, an ongoing pandemic of COVID-19, places a dreadful burden on the
healthcare system worldwide. Subsequently, there is a need for a rapid, user-friendly, and …
healthcare system worldwide. Subsequently, there is a need for a rapid, user-friendly, and …
COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva
N Pisanic, PR Randad, K Kruczynski… - Journal of clinical …, 2020 - Am Soc Microbiol
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of an ongoing
pandemic that has infected over 36 million and killed over 1 million people. Informed …
pandemic that has infected over 36 million and killed over 1 million people. Informed …
Emerging biosensing technologies for the diagnostics of viral infectious diseases
Several viral infectious diseases appear limitless since the beginning of the 21st century,
expanding into pandemic lengths. Thus, there are extensive efforts to provide more efficient …
expanding into pandemic lengths. Thus, there are extensive efforts to provide more efficient …